274 related articles for article (PubMed ID: 28910420)
21. Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils.
Bocharova OV; Breydo L; Salnikov VV; Baskakov IV
Biochemistry; 2005 May; 44(18):6776-87. PubMed ID: 15865423
[TBL] [Abstract][Full Text] [Related]
22. PrP aggregation can be seeded by pre-formed recombinant PrP amyloid fibrils without the replication of infectious prions.
Barron RM; King D; Jeffrey M; McGovern G; Agarwal S; Gill AC; Piccardo P
Acta Neuropathol; 2016 Oct; 132(4):611-24. PubMed ID: 27376534
[TBL] [Abstract][Full Text] [Related]
23. Reduction of prion infectivity and levels of scrapie prion protein by lithium aluminum hydride: implications for RNA in prion diseases.
Jeong BH; Kim NH; Jin JK; Choi JK; Lee YJ; Kim JI; Choi EK; Carp RI; Kim YS
J Neuropathol Exp Neurol; 2009 Aug; 68(8):870-9. PubMed ID: 19606066
[TBL] [Abstract][Full Text] [Related]
24. Protease resistance of infectious prions is suppressed by removal of a single atom in the cellular prion protein.
Leske H; Hornemann S; Herrmann US; Zhu C; Dametto P; Li B; Laferriere F; Polymenidou M; Pelczar P; Reimann RR; Schwarz P; Rushing EJ; Wüthrich K; Aguzzi A
PLoS One; 2017; 12(2):e0170503. PubMed ID: 28207746
[TBL] [Abstract][Full Text] [Related]
25. The role of glycophosphatidylinositol anchor in the amplification of the scrapie isoform of prion protein in vitro.
Kim JI; Surewicz K; Gambetti P; Surewicz WK
FEBS Lett; 2009 Nov; 583(22):3671-5. PubMed ID: 19854187
[TBL] [Abstract][Full Text] [Related]
26. PK-sensitive PrP is infectious and shares basic structural features with PK-resistant PrP.
Sajnani G; Silva CJ; Ramos A; Pastrana MA; Onisko BC; Erickson ML; Antaki EM; Dynin I; Vázquez-Fernández E; Sigurdson CJ; Carter JM; Requena JR
PLoS Pathog; 2012; 8(3):e1002547. PubMed ID: 22396643
[TBL] [Abstract][Full Text] [Related]
27. Sensitive and specific detection of classical scrapie prions in the brains of goats by real-time quaking-induced conversion.
Dassanayake RP; Orrú CD; Hughson AG; Caughey B; Graça T; Zhuang D; Madsen-Bouterse SA; Knowles DP; Schneider DA
J Gen Virol; 2016 Mar; 97(3):803-812. PubMed ID: 26653410
[TBL] [Abstract][Full Text] [Related]
28. Reversibility of scrapie-associated prion protein aggregation.
Callahan MA; Xiong L; Caughey B
J Biol Chem; 2001 Jul; 276(30):28022-8. PubMed ID: 11375994
[TBL] [Abstract][Full Text] [Related]
29. Ultrastructure and pathology of prion protein amyloid accumulation and cellular damage in extraneural tissues of scrapie-infected transgenic mice expressing anchorless prion protein.
Race B; Jeffrey M; McGovern G; Dorward D; Chesebro B
Prion; 2017 Jul; 11(4):234-248. PubMed ID: 28759310
[TBL] [Abstract][Full Text] [Related]
30. Protease-resistant and detergent-insoluble prion protein is not necessarily associated with prion infectivity.
Shaked GM; Fridlander G; Meiner Z; Taraboulos A; Gabizon R
J Biol Chem; 1999 Jun; 274(25):17981-6. PubMed ID: 10364247
[TBL] [Abstract][Full Text] [Related]
31. A Mass Spectrometry-Based Method of Quantifying the Contribution of the Lysine Polymorphism at Position 171 in Sheep PrP.
Silva CJ; Cassmann ED; Greenlee JJ; Erickson-Beltran ML; Requena JR
J Am Soc Mass Spectrom; 2023 Feb; 34(2):245-254. PubMed ID: 36622794
[TBL] [Abstract][Full Text] [Related]
32. Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform.
James TL; Liu H; Ulyanov NB; Farr-Jones S; Zhang H; Donne DG; Kaneko K; Groth D; Mehlhorn I; Prusiner SB; Cohen FE
Proc Natl Acad Sci U S A; 1997 Sep; 94(19):10086-91. PubMed ID: 9294167
[TBL] [Abstract][Full Text] [Related]
33. Amyloid fibrils from the N-terminal prion protein fragment are infectious.
Choi JK; Cali I; Surewicz K; Kong Q; Gambetti P; Surewicz WK
Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13851-13856. PubMed ID: 27849581
[TBL] [Abstract][Full Text] [Related]
34. A Promising Antiprion Trimethoxychalcone Binds to the Globular Domain of the Cellular Prion Protein and Changes Its Cellular Location.
Ferreira NC; Ascari LM; Hughson AG; Cavalheiro GR; Góes CF; Fernandes PN; Hollister JR; da Conceição RA; Silva DS; Souza AMT; Barbosa MLC; Lara FA; Martins RAP; Caughey B; Cordeiro Y
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133563
[TBL] [Abstract][Full Text] [Related]
35. Prion protein amyloid: separation of scrapie infectivity from PrP polymers.
Wille H; Baldwin MA; Cohen FE; DeArmond SJ; Prusiner SB
Ciba Found Symp; 1996; 199():181-99; discussion 199-201. PubMed ID: 8915611
[TBL] [Abstract][Full Text] [Related]
36. Epitope scanning reveals gain and loss of strain specific antibody binding epitopes associated with the conversion of normal cellular prion to scrapie prion.
Pan T; Li R; Kang SC; Wong BS; Wisniewski T; Sy MS
J Neurochem; 2004 Sep; 90(5):1205-17. PubMed ID: 15312175
[TBL] [Abstract][Full Text] [Related]
37. A new mechanism for transmissible prion diseases.
Makarava N; Kovacs GG; Savtchenko R; Alexeeva I; Ostapchenko VG; Budka H; Rohwer RG; Baskakov IV
J Neurosci; 2012 May; 32(21):7345-55. PubMed ID: 22623680
[TBL] [Abstract][Full Text] [Related]
38. Role of the highly conserved middle region of prion protein (PrP) in PrP-lipid interaction.
Wang F; Yin S; Wang X; Zha L; Sy MS; Ma J
Biochemistry; 2010 Sep; 49(37):8169-76. PubMed ID: 20718504
[TBL] [Abstract][Full Text] [Related]
39. Methamphetamine increases Prion Protein and induces dopamine-dependent expression of protease resistant PrPsc.
Ferrucci M; Ryskalin L; Biagioni F; Gambardella S; Busceti CL; Falleni A; Lazzeri G; Fornai F
Arch Ital Biol; 2017 Jul; 155(1-2):81-97. PubMed ID: 28715601
[TBL] [Abstract][Full Text] [Related]
40. Non-glycosylphosphatidylinositol (GPI)-anchored recombinant prion protein with dominant-negative mutation inhibits PrPSc replication in vitro.
Kishida H; Sakasegawa Y; Watanabe K; Yamakawa Y; Nishijima M; Kuroiwa Y; Hachiya NS; Kaneko K
Amyloid; 2004 Mar; 11(1):14-20. PubMed ID: 15185494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
